#leqembi

[joelekm]

FDA Approves Leqembi for Alzheimer's: A New Hope for Families | B As A Butterfly

This video on the FDA approval of Leqembi for Alzheimer’s is really worth watching. The new auto-injector could mean less hospital visits and more quality time for families.

[fsamson6]

Leqembi - Progress in Alzheimer’s Treatment

Claire Day has been on staff of the Alzheimer’s Association since 2001. She is the Chief Program Officer at the Northern California and Northern Nevada Chapter and as such, oversees all care and support operations and research initiatives. Ms. Day is a clinical social worker and received her degree from Bloomsburg University of Pennsylvania. She has more than twenty years of experience as a family and professional educator in dementia care and has authored two forwards to Alzheimer’s caregiver books. In 2018, Ms. Day was appointed the Chapter Lead for the US Study to Protect Brain Health Through Lifestyle Interventions to Reduce Risk (US POINTER) in California in partnership with U.C. Davis. US POINTER is a two-year clinical trial to evaluate whether lifestyle interventions that simultaneously target multiple risk factors protect cognitive function in older adults at increased risk for cognitive decline. www.SeniorCareAuthority.com

[caregivervent]

FDA gives full approval to controversial Alzheimer's drug, Leqembi

Last week, the Food and Drug Administration (FDA) granted full approval to Leqembi, an Alzheimer’s treatment that has shown some moderate benefits in those in the early stages of the disease, but also has potential side effects that are concerning to some medical professionals. While the drug received accelerated approval earlier this year, the full approval designation will mean that Medicare…

View On WordPress